Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT

Abstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this pro...

Full description

Bibliographic Details
Main Authors: Jiale Hou, Tingting Long, Zhiyou He, Ming Zhou, Nengan Yang, Dengming Chen, Shan Zeng, Shuo Hu
Format: Article
Language:English
Published: SpringerOpen 2021-06-01
Series:EJNMMI Research
Online Access:https://doi.org/10.1186/s13550-021-00797-4
id doaj-3fe331ed0f334de3a82ab5a8e057eae1
record_format Article
spelling doaj-3fe331ed0f334de3a82ab5a8e057eae12021-06-13T11:29:09ZengSpringerOpenEJNMMI Research2191-219X2021-06-011111910.1186/s13550-021-00797-4Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CTJiale Hou0Tingting Long1Zhiyou He2Ming Zhou3Nengan Yang4Dengming Chen5Shan Zeng6Shuo Hu7Department of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Cancer Chemotherapy, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityAbstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this prospective study. We compared the biodistribution profiles in normal organs based on the maximum standard uptake value (SUVmax) and mean standard uptake value (SUVmean), and uptake in NEN lesions by measuring the SUVmax on 18F-OC and 68Ga-DOTATATE PET/CT images. The tumor-to-liver ratio (TLR) and tumor-to-spleen ratio were calculated by dividing the SUVmax of different tumor lesions by the SUVmean of the liver and spleen, respectively. The Wilcoxon signed-rank test was used to compare nonparametric data. Data were expressed as the median (interquartile range). Results In most organs, there were no significant differences in the biodistribution of 68Ga-DOTATATE and 18F-OC. 18F-OC had significantly lower uptake in the salivary glands and liver than 68Ga-DOTATATE. 18F-OC detected more lesions than 68Ga-DOTATATE. The uptake of 18F-OC in the tumors was higher in most patients, but the difference was not statistically significant relative to that of 68Ga-DOTATATE. However, the TLRs of 18F-OC were higher in most patients, including for lesions in the liver (p = 0.02) and lymph nodes (p = 0.02). Conclusion Relative to 68Ga-DOTATATE, 18F-OC possesses favorable characteristics with similar image quality and satisfactory NEN lesion detection rates, especially in the liver due to its low background uptake. 18F-OC therefore offers a promising clinical alternative for 68Ga-DOTATATE.https://doi.org/10.1186/s13550-021-00797-4
collection DOAJ
language English
format Article
sources DOAJ
author Jiale Hou
Tingting Long
Zhiyou He
Ming Zhou
Nengan Yang
Dengming Chen
Shan Zeng
Shuo Hu
spellingShingle Jiale Hou
Tingting Long
Zhiyou He
Ming Zhou
Nengan Yang
Dengming Chen
Shan Zeng
Shuo Hu
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
EJNMMI Research
author_facet Jiale Hou
Tingting Long
Zhiyou He
Ming Zhou
Nengan Yang
Dengming Chen
Shan Zeng
Shuo Hu
author_sort Jiale Hou
title Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
title_short Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
title_full Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
title_fullStr Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
title_full_unstemmed Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
title_sort evaluation of 18f-alf-nota-octreotide for imaging neuroendocrine neoplasms: comparison with 68ga-dotatate pet/ct
publisher SpringerOpen
series EJNMMI Research
issn 2191-219X
publishDate 2021-06-01
description Abstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this prospective study. We compared the biodistribution profiles in normal organs based on the maximum standard uptake value (SUVmax) and mean standard uptake value (SUVmean), and uptake in NEN lesions by measuring the SUVmax on 18F-OC and 68Ga-DOTATATE PET/CT images. The tumor-to-liver ratio (TLR) and tumor-to-spleen ratio were calculated by dividing the SUVmax of different tumor lesions by the SUVmean of the liver and spleen, respectively. The Wilcoxon signed-rank test was used to compare nonparametric data. Data were expressed as the median (interquartile range). Results In most organs, there were no significant differences in the biodistribution of 68Ga-DOTATATE and 18F-OC. 18F-OC had significantly lower uptake in the salivary glands and liver than 68Ga-DOTATATE. 18F-OC detected more lesions than 68Ga-DOTATATE. The uptake of 18F-OC in the tumors was higher in most patients, but the difference was not statistically significant relative to that of 68Ga-DOTATATE. However, the TLRs of 18F-OC were higher in most patients, including for lesions in the liver (p = 0.02) and lymph nodes (p = 0.02). Conclusion Relative to 68Ga-DOTATATE, 18F-OC possesses favorable characteristics with similar image quality and satisfactory NEN lesion detection rates, especially in the liver due to its low background uptake. 18F-OC therefore offers a promising clinical alternative for 68Ga-DOTATATE.
url https://doi.org/10.1186/s13550-021-00797-4
work_keys_str_mv AT jialehou evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT tingtinglong evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT zhiyouhe evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT mingzhou evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT nenganyang evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT dengmingchen evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT shanzeng evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
AT shuohu evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct
_version_ 1721379761481056256